MolecuLight Announces Industry Partnership and Virtual Exhibit of its MolecuLight i:X Platform at WoundCon™ 2020, the Largest Worldwide Conference for Wound Care

DMCA.com Protection Status
Keywords: 
Blog Category: 

By Industry News

Toronto, CANADA and Atlantic Beach, USA – April 1, 2020 – MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces its Sponsorship and participation in the Virtual Exhibit of its MolecuLight i:X® Platform at WoundCon™ Spring 2020. The virtual digital conference (www.woundcon.com) will be held on April 2, 2020 and has become the largest global conference for wound care, with over 11,500 wound care professionals registered for the
1-day clinical conference and virtual exhibition.

“We are proud to be supporting WoundCon Spring 2020 and are thrilled with the unprecedented attendance of wound care professionals registered to attend the scientific sessions, as well as the virtual exhibits, where we will be profiling our MolecuLight i:X platform”, says Anil Amlani, MolecuLight’s CEO. “Given the COVID-19 challenges that are restricting travel, public meetings, as well as the limited time available to medical professionals for conference learning and sharing, WoundCon is an excellent alternative to support global collaboration of best practices and novel technologies in wound care”.

As Silver Sponsors of the event, MolecuLight is providing educational support for two talks as part of the scientific program – “The Four Ws of Wound Management – Who, What, When, and Why of Choosing Therapeutic Interventions” and “Key Wound Infection Management Strategies”. MolecuLight is also profiling its MolecuLight i:X point-of-care imaging system for the detection of bacteria in wounds, as well as digital wound measurement, in the Virtual Exhibit Hall. MolecuLight’s virtual trade show booth will include detailed descriptions and demonstrations of the MolecuLight procedure and workflow, many examples of the significant body of published evidence demonstrating the clinical utility, and customer testimonial videos.

“MolecuLight’s novel diagnostic imaging platform represents a major paradigm shift in wound care diagnosis and point-of-care imaging and is of real interest to our wound care audience, “says Miranda J. Henry, Editorial Director of WoundSource® (Kestrel Health Information is the publisher of WoundSource and is also the producer of WoundCon Spring 2020). “WoundCon is the first ever virtual wound care conference and expo and we are thrilled to have MolecuLight both as a premier Silver Industry Partner and as a participant with their dynamic virtual trade show booth in our exhibit hall”.

About MolecuLight Inc.
MolecuLight Inc. (www.moleculight.com) is a privately owned Canadian medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical and commercial markets. MolecuLight’s initial product, the MolecuLight i:X®, and its accessories delivers a real-time handheld fluorescence imaging solution for the global wound care market. The MolecuLight i:X provides clinicians with information about the fluorescent characteristics of wounds to assist clinicians in making improved diagnostic and treatment decisions. The company is also commercializing its unique fluorescence imaging platform technology for other markets with globally relevant, unmet needs including food safety, consumer cosmetics and other key industrial markets.

The views and opinions expressed in this blog are solely those of the author, and do not represent the views of WoundSource, Kestrel Health Information, Inc., its affiliates, or subsidiary companies.

Related company: 

Recommended for You

  • WoundSource 2019
    August 22nd, 2019

    By Miranda J. Henry, Editorial Director of WoundSource

    This updated edition of WoundSource provides a glimpse of the continuing evolution of the field of wound care. There are several additions this year that reflect the innovation and ingenuity we are seeing in wound...

Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute manufacturer instructions. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Refer to the Legal Notice for express terms of use.